The girl is intractable cancerAfter what scientists call the most advanced cell engineering, her body was purified.
Alyssa, who does not want her surname to be revealed, was diagnosed as having acute T-cell lymphoblastic (T-cell) leukemia in May 2021.
Doctors told her parents that they couldn’t do anything after a round of chemotherapy failed to cure the 13-year old.
The next step for her was palliative care. Instead, Alyssa chose to undergo a new experimental treatment.
Scientists from Great Ormond Street Hospital for Children in London modified the cells of their prefabricated cells with a new technology. This allowed them to hunt down cancerous T cells and destroy them without attacking each others.
T cells are a type if white blood cells that move around the body to kill and find damaged cells.
This is the first treatment of its type in the world. Alyssa’s healing will bring hope to thousands of patients.
The girl stated that she believed that the experimental treatment for the disease would be beneficial to others and added, “Ofcourse, I will.”
Within a month of receiving treatment, she was in remission. She was then able to receive a second bone transplant.
She is “doing well at her home” as she recovers from surgery and continues to keep watch.
Keona, Keona’s mom, stated that the family was “on an odd cloud nine” and that it was great to be home.
She said, “Hopefully this proves that the research works and can be introduced to more children – it all must be for something.”
The scientists now hope to recruit as many as 10 patients with T-cell Leukemia just like Elisa who has exhausted all other options for a clinical trial.
They hope it will work and be available to children sooner, when they are less sick, so that it can be used for other types in the future.
NHS professionals will refer potential patients for trials.
Professor Waseem Qasim is a consultant immunologist at GOSH. He said, “This is amazing evidence of how cutting-edge technology in the laboratory can link to real outcomes in hospital, for patients, with expert team members and infrastructure.
It’s our most advanced cell engineering to date and opens the door for new therapies and a better future.
“We have a unique and privileged environment here at GOSH that allows us to rapidly scale new technologies and we look forward to continuing our research and bringing it to the patients who need it most.”
Send an email to our news team at webnews@metro.co.uk.
You can read more stories like these. Check out our news page.
Get the latest news, happy stories and analysis
Source link
[Denial of responsibility! wideworldmag.co.uk is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – at wideworldmag.co.uk The content will be deleted within 24 hours.]
